arrow
L

Lawrence I. Golbe

Rutgers Robert Wood Johnson Medical School
H指数:58
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Montreal cognitive assessment as a cognitive outcome measure in progressive supranuclear palsy

蒙特利尔认知评估作为进行性核上性麻痹的认知结局指标

2024-12-040
OA
Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes

进行性核上性麻痹的遗传,转录组,组织学和生化分析涉及神经胶质激活和新的风险基因

2024-09-090
OAAI
Novel avenues of tau research
2024-01-035
OAAI
Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration
2023-06-014
OA
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021)

抗tau单克隆抗体gosuranemab治疗进行性核上性麻痹的安全性和有效性: 一项2期,随机,安慰剂对照试验 (8月,10.1038/s41591-021-01455-x,2021)

2022-10-171
OA
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

抗tau单克隆抗体gosuranemab治疗进行性核上性麻痹的安全性和有效性: 一项2期随机安慰剂对照试验

2021-08-1280
PREAI
A Modified Progressive Supranuclear Palsy Rating Scale
2021-01-2915
OA
Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression

路易体痴呆杏仁核内独特的 α-突触核蛋白病理学: 对疾病起始和进展的影响

2019-09-0253
OAAI
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy
2019-03-18105
OAAI